Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-03 @ 10:36 AM
Study NCT ID:
NCT03235869
Status:
WITHDRAWN
Last Update Posted:
2018-03-15
First Post:
2017-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-27
First Submit QC Date:
None
Study First Post Date:
2017-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-13
Last Update Post Date:
2018-03-15
Last Update Post Date Type:
ACTUAL